NP Life Sciences Health Industry Group Inc. (ACAT) Return on equity 2019–2023
NP Life Sciences Health Industry Group Inc. (ACAT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-17.9%FY2023 · since FY2019: -46.3% → -17.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -17.9% | +79.7 pp |
| FY2022 | -97.6% | +74.4 pp |
| FY2021 | -172.1% | -45.8 pp |
| FY2020 | -126.2% | -79.9 pp |
| FY2019 | -46.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice